Correlation Between UST Inc and Universe Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both UST Inc and Universe Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining UST Inc and Universe Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between ProShares Ultra 7 10 and Universe Pharmaceuticals, you can compare the effects of market volatilities on UST Inc and Universe Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in UST Inc with a short position of Universe Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of UST Inc and Universe Pharmaceuticals.

Diversification Opportunities for UST Inc and Universe Pharmaceuticals

0.42

Correlation Coefficient

UST Inc  Universe Pharmaceuticals

Very weak diversification

The 3 months correlation between UST and Universe is 0.42. Overlapping area represents the amount of risk that can be diversified away by holding ProShares Ultra 7 10 and Universe Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Universe Pharmaceuticals and UST Inc is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ProShares Ultra 7 10 are associated (or correlated) with Universe Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Universe Pharmaceuticals has no effect on the direction of UST Inc i.e., UST Inc and Universe Pharmaceuticals go up and down completely randomly.

Pair Corralation between UST Inc and Universe Pharmaceuticals

Considering the 90-day investment horizon ProShares Ultra 7 10 is expected to generate 0.05 times more return on investment than Universe Pharmaceuticals. However, ProShares Ultra 7 10 is 21.34 times less risky than Universe Pharmaceuticals. It trades about 0.01 of its potential returns per unit of risk. Universe Pharmaceuticals is currently generating about -0.05 per unit of risk. If you would invest  4,250  in ProShares Ultra 7 10 on December 2, 2024 and sell it today you would earn a total of  59.00  from holding ProShares Ultra 7 10 or generate 1.39% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

ProShares Ultra 7 10  vs.  Universe Pharmaceuticals

ProShares Ultra 7

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in ProShares Ultra 7 10 are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, UST Inc is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

Universe Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Universe Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in April 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Pair Trading with UST Inc and Universe Pharmaceuticals

The main advantage of trading using opposite UST Inc and Universe Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if UST Inc position performs unexpectedly, Universe Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Universe Pharmaceuticals will offset losses from the drop in Universe Pharmaceuticals' long position.

The idea behind ProShares Ultra 7 10 and Universe Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.